Maier Paul V

Maier Paul V is listed in filings as Director at International Stem Cell Corporation. This profile follows SEC Form 4 activity through Jun 23, 2026, including 5 public disclosures. Recent filings connect the profile to International Stem Cell Corporation (ISCO) and Eton Pharmaceuticals, Inc. (ETON). The current snapshot covers public activity from Jan 6, 2025 to Jun 23, 2026. Reported amounts are shown as $32.5K to $325.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.